{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:23:12Z","timestamp":1790677392499,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003192","name":"BEVICA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ymgme.2014.02.015","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T05:02:13Z","timestamp":1394082133000},"page":"40-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease\u2014a long-term follow-up"],"prefix":"10.1016","volume":"112","author":[{"given":"Christer Swan","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M\u00f8rup","family":"Schl\u00fctter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.02.015_bb0005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France: genotype\u2013phenotype correlation","volume":"55","author":"Laforet","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2014.02.015_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2014.02.015_bb0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"Muller-Felber","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0020","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: a prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2014.02.015_bb0025","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-010-9204-5","article-title":"Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response","volume":"33","author":"Ravaglia","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0035","series-title":"Disorders of Voluntary Muscle","first-page":"1771","article-title":"Clinical examination, differential diagnosis and classification","author":"Walton","year":"1994"},{"key":"10.1016\/j.ymgme.2014.02.015_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00421-011-1975-3","article-title":"Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects","volume":"112","author":"Harbo","year":"2012","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00125-009-1320-0","article-title":"Accelerated atrophy of lower leg and foot muscles\u2014a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI)","volume":"52","author":"Andreassen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.ymgme.2014.02.015_bb0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"van der Ploeg","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/mus.20896","article-title":"Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease","volume":"37","author":"Drost","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2014.02.015_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(73)90023-3","article-title":"Data on the distribution of fibre types in thirty-six human muscles. An autopsy study","volume":"18","author":"Johnson","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01003594","article-title":"Muscle fibre type populations of human leg muscles","volume":"7","author":"Edgerton","year":"1975","journal-title":"Histochem. J."},{"key":"10.1016\/j.ymgme.2014.02.015_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(81)90005-8","article-title":"Human vastus lateralis and gastrocnemius muscles. A comparative histochemical and biochemical analysis","volume":"52","author":"Green","year":"1981","journal-title":"J. Neurol. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T02:23:25Z","timestamp":1538792605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1096719214000870"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.02.015","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease\u2014a long-term follow-up","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}